Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7000
+0.0500 (7.69%)
Jul 31, 2026, 3:56 PM HKT

HKG:3737 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,7371,7372,2152,0501,8261,747
Revenue Growth
-13.42%-21.55%8.05%12.26%4.55%8.89%
Gross Profit
940.25940.251,2811,2151,0671,061
Operating Income
-1.67-1.67125.14164.4103.5179.58
Net Income
17.2917.2995.21162.78106.3952.13
Earnings Per Share
0.020.020.110.190.130.06
EPS Growth
-4.09%-81.82%-42.11%51.27%109.34%-64.10%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operation of Chain Pharmacies
528.81528.81590.49634.15696.03693.22
Elimination of Intersegment Sales
-592.07-592.07-708.24-696.22-717.95-823.96
Pharmaceutical Manufacturing
1,8011,8012,3332,1121,8481,877
Total
1,7371,7372,2152,0501,8261,747

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
198.92198.92199.69192.3419.36257.85
Total Debt
130.01130.01188.6174.86170.86175.74
Net Cash (Debt)
68.9168.9111.0917.45248.582.1
Net Cash Growth
87.19%521.45%-36.45%-92.98%202.67%-33.32%
Net Cash Per Share
0.080.080.010.020.290.10

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
179.7179.7181.48101.5284.57178.38
Capital Expenditures
-35.22-35.22-140.76-169.18-88.41-185.85
Free Cash Flow
144.47144.4740.72-67.68196.17-7.47
Free Cash Flow Growth
8.13%254.76%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.12%54.12%57.85%59.25%58.45%60.77%
Operating Margin
-0.10%-0.10%5.65%8.02%5.67%4.56%
Pretax Margin
1.09%1.09%6.63%10.13%7.16%3.54%
Profit Margin
1.00%1.00%4.30%7.94%5.83%2.99%
FCF Margin
8.31%8.31%1.84%-3.30%10.74%-0.43%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.050-0.0470.0820.053
Dividend Per Share Growth
-44.44%--42.49%53.92%-
Dividend Yield
7.14%-5.35%6.90%6.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
31.4525.148.446.847.8313.36
Forward PE
-10.3010.3010.3010.3010.30
P/FCF Ratio
3.763.0119.73-4.25-
PS Ratio
0.310.250.360.540.460.40